跳至主要内容
临床试验/NCT05462223
NCT05462223Unknown不适用

A Study of the Safety and Feasibility of the Vessel Restoration System for AVF to Promote the Physiologic and Functional Maturation of Upper-extremity Autologous End-to-Side Arteriovenous Fistulas (AVF) in Patients With Chronic Kidney Disease: ACTIVATE AVF

Alucent Biomedical21 个研究点 分布在 2 个国家目标入组 30 人开始时间: 2022年7月15日最近更新:
适应症
干预措施

试验速览

阶段
不适用
发起方
入组人数
30
试验地点
21
主要终点
AVF Maturation

研究概览

简要总结

Feasibility of the Vessel Restoration System for AVF

详细描述

A study of the safety and feasibility of the Vessel Restoration System for AVF to promote the physiologic and functional maturation of a Brachiocephalic End-to-Side Arteriovenous Fistulas (AVF) in Patients with Chronic Kidney Disease Stage V (Pre-dialysis): ACTIVATE AVF

研究设计

研究类型
Interventional
分配方式
Na
干预模型
Sequential
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • 18 years of age and can provide informed consent
  • Use birth control
  • Chronic Kidney Disease

排除标准

  • Receiving hemodialysis
  • Pregnant, breastfeeding, planning to become pregnant
  • Receiving immunosuppressants
  • Has "Long COVID"

研究组 & 干预措施

Alucent VRS for Treatment of Atherosclerotic Lesions

Experimental

Alucent Vessel Restoration System for AVF (VRS-AVF) consists of the following components:

  1. VRS 10-8-10 Dimer Coated Balloon Catheter for AVF
  2. VRS Light Fiber
  3. VRS Light Source

干预措施: Alucent Vessel Restoration System for AVF (Combination Product)

结局指标

主要结局

AVF Maturation

时间窗: 2 weeks to 3 months

Unassisted AVF Maturation using a fistulagram and needle sticks to assess maturation at specific time points

次要结局

未报告次要终点

研究者

发起方
Alucent Biomedical
申办方类型
Industry
责任方
Sponsor

研究点 (21)

Loading locations...

相似试验